STAAR Surgical Company
STAAR Surgical Company (STAA) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · STAA · as of Sep 30, 2025
Ownership Breakdown
212
Institutional Holders
▲ 35 vs Q2
$1.36B
Total Inst. Value
▲ $455.04M vs Q2
49.79M
Shares Outstanding
freeFloat 99.20%
50.62M
13F Shares Held
▼ 3.28M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
STAA largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BROADWOOD CAPITAL INC ophthalmic goods | 13.52M | 27.30% | 27.30% | $363.27B | Nov 14, 2025 | — held |
BLACKROCK, INC. ophthalmic goods | 7.26M | 14.66% | 14.66% | $195.05B | Nov 12, 2025 | ▼ 112.2K |
VANGUARD GROUP INC ophthalmic goods | 4.27M | 8.62% | 8.62% | $114.71B | Nov 7, 2025 | ▼ 121.6K |
YUNQI CAPITAL LTD ophthalmic goods | 2.50M | 5.05% | 5.05% | $67.18B | Nov 21, 2025 | ▲ 88.8K |
STATE STREET CORP ophthalmic goods | 1.91M | 3.86% | 3.86% | $51.35B | Nov 14, 2025 | ▼ 91.9K |
BALYASNY ASSET MANAGEMENT L.P. ophthalmic goods | 1.81M | 3.66% | 3.66% | $48.73B | Nov 14, 2025 | NEW |
MAGNETAR FINANCIAL LLC ophthalmic goods | 1.20M | 2.43% | 2.43% | $32.36B | Nov 13, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC ophthalmic goods | 1.17M | 2.37% | 2.37% | $31.55B | Nov 12, 2025 | ▼ 19.0K |
GOLDMAN SACHS GROUP INC ophthalmic goods | 976.3K | 1.97% | 1.97% | $26.23B | Nov 14, 2025 | ▲ 794.0K |
ALPINE ASSOCIATES MANAGEMENT INC. ophthalmic goods | 913.1K | 1.84% | 1.84% | $24.53B | Nov 6, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
13
Increased
+1.78M shares20
New Positions
first time holders16
Decreased
−4.63M shares0
Sold Out
fully exitedNet shares change (top 50)
2.85M
+1.78M / −4.63M
Net new holders
+17
20 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
STAA insider trading · insider activity
Source: SEC Form 4
30
Buy transactions
9
Sell transactions
3.33
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
ANDREWS DEBORAH J Interim Co-CEO and CFO | May 15, 2026 | Award | 5,233 | — | — | 20.5K | Form 4 ↗ |
ANDREWS DEBORAH J Interim Co-CEO and CFO | May 15, 2026 | Tax Withhold | 1,877 | $32.07 | $60.2K | 18.7K | Form 4 ↗ |
ANDREWS DEBORAH J Interim Co-CEO and CFO | May 15, 2026 | Tax Withhold | 3,755 | $32.07 | $120.4K | 15.3K | Form 4 ↗ |
ANDREWS DEBORAH J Interim Co-CEO and CFO | May 15, 2026 | Award | 10,466 | — | — | 10.5K | Form 4 ↗ |
Foust Warren Interim Co-CEO and Pres. & COO | May 15, 2026 | Award | 7,331 | — | — | 85.1K | Form 4 ↗ |
Foust Warren Interim Co-CEO and Pres. & COO | May 15, 2026 | Award | 3,666 | — | — | 85.0K | Form 4 ↗ |
Foust Warren Interim Co-CEO and Pres. & COO | May 15, 2026 | Tax Withhold | 1,865 | $32.07 | $59.8K | 83.1K | Form 4 ↗ |
Foust Warren Interim Co-CEO and Pres. & COO | May 15, 2026 | Award | 14,662 | — | — | 81.6K | Form 4 ↗ |
Foust Warren Interim Co-CEO and Pres. & COO | May 15, 2026 | Award | 7,331 | — | — | 81.5K | Form 4 ↗ |
Foust Warren Interim Co-CEO and Pres. & COO | May 15, 2026 | Tax Withhold | 3,730 | $32.07 | $119.6K | 81.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
STAAR Surgical Company (STAA) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.80%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of STAAR Surgical Company is BROADWOOD CAPITAL INC, holding approximately 13.52 million shares — equal to 27.30% of outstanding shares — as of September 30, 2025.
A total of 212 institutional investors currently hold STAA stock, with a combined institutional value of approximately $1.36 billion as of the most recent 13F filing period.
Frequently asked questions
STAA ownershipSTAAR Surgical Company (STAA) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BROADWOOD CAPITAL INC with a 27.30% stake. Company insiders hold 0.80%. Data sourced from SEC Form 13F as of September 30, 2025.